A longitudinal study of children identifies antibody Fc-mediated functions and antigen targets of immunity to Plasmodium vivax malaria
Plasmodium vivax is the most widespread cause of malaria with a high burden of disease. Progress in reducing the global malaria burden has stalled with no vaccines available partly due to a limited knowledge of targets and mechanisms of protective immunity. We developed a platform to quantify antibody functions to multiple P. vivax antigens and dissect immunity in a longitudinal cohort of children from Papua New Guinea at risk of P. vivax malaria. We identified antigens targeted by multiple functional antibodies, including interactions with Fcγ receptors, which mediate different cellular effector functions, and complement fixation, advancing our understanding of P. vivax immunity. We identified specific antigens targeted by antibodies associated with protection from P. vivax malaria. Evaluating thousands of possible combinations, we identified subsets of antigens in the most protective combinations providing leads for developing highly protective multi-antigen P. vivax vaccines eliciting multi-functional antibody responses to achieve and sustain elimination.
Authors
- Yanie Tayipto
- Linda Reiling
- Jessica Brewster
- Wines Bd
- Kael L. Schoffer (ORCID: https://orcid.org/0000-0002-5683-9935)
- Tim Spelman
- Rhea J. Longley (ORCID: https://orcid.org/0000-0002-4510-5602)
- Mark Hogarth
- Matthias Harbers
- Benson Kiniboro
- James G. Beeson
- Peter Siba
- Ivo Mueller
- Takafumi Tsuboi
- Leanne J. Robinson
- D. Herbert Opi
- Eizo Takashima
Institutions
- Burnet Institute (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Matsuyama University (JP)
- CellFree Sciences (Japan) (JP)
- Ehime University (JP)
- Papua New Guinea Institute of Medical Research (PG)
Publication Details
- Journal
- Immunity
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1016/j.immuni.2026.02.003
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Burnet Institute
- Japan Agency for Medical Research and Development
- Veski
- State Government of Victoria
- National Institutes of Health
- National Health and Medical Research Council